Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer

Journal article

Peer reviewed

M. E SANDS, G. K ZAGARS, A POLLACK and A. C VON ESCHENBACH

Urology (Ridgewood, N.J.), Vol.44(2), pp.215-220

1994

PMID: 7519381

Abstract

Tumors of the urinary system

Urinary tract. Prostate gland

Nephrology. Urinary tract diseases

Biological and medical sciences

Medical sciences

10 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.97 Prostate Cancer
Web Of Science research areas: Urology & Nephrology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Serum prostate-specific antigen, clinical stage, pathologic grade, and the incidence of nodal metastases in prostate cancer
Creators: M. E SANDS - Univ. Texas M.D. Anderson cancer cent., dep. clin. radiotherapy urology, Houston TX, United States
G. K ZAGARS - Univ. Texas M.D. Anderson cancer cent., dep. clin. radiotherapy urology, Houston TX, United States
A POLLACK - Univ. Texas M.D. Anderson cancer cent., dep. clin. radiotherapy urology, Houston TX, United States
A. C VON ESCHENBACH - Univ. Texas M.D. Anderson cancer cent., dep. clin. radiotherapy urology, Houston TX, United States
Publication Details: Urology (Ridgewood, N.J.), Vol.44(2), pp.215-220
Publisher: Elsevier Science; New York, NY
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
PMID: 7519381
Record Identifier: 991031560032502976